Additional Information

Research Summary
Dr. Chung is focused on mining of biomarkers for solid tumors, especially gastrointestinal and gynecologic cancers. He uses his expertise in tissue-based biomarkers in the lab to develop novel radiopharmaceutical agents for cancer therapy.

Areas of Expertise
1)    Tissue-based biomarkers, 2) Digital image analysis, 3) Molecular biology, 
4) Gastrointestinal cancer, 5) Gynecologic cancer


Dr. Joon-Yong Chung obtained his Ph.D. in microbiology from the Hallym University College of Medicine, South Korea in 1999. Before joining the NCI, he was an Assistant Professor at the Inje University of Medicine, South Korea. There, he studied Plasmodium vivax and immunological characteristics of human parasites. He joined the NCI-CCR’s Lab of Pathology Branch as a postdoctoral fellow in 2003. He focused on the development of reliable proteomic profiling methodologies for formalin-fixed paraffin-embedded (FFPE)-protein during his postdoctoral fellowship. From 2009 to 2022, he worked as a research biologist in the NCI-CCR’s Lab of Pathology Branch. During this time, he focused on genetic and proteomic analyses of FFPE tissues. He is involved in the development of advanced technologies including biomolecular extraction, and new generation fixatives. His areas of interest include the development of tissue-based biomarkers for cancer diagnosis, prognosis, and prediction of response to therapy, as well as genetic alteration after chemoradiation therapy in non-small cell lung cancers, gastrointestinal and gynecologic cancers. In 2022, he transferred to Dr. Escorcia’ s lab in the Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute. Currently, he is an associate editor of Frontiers in Oncology and Frontiers in Genetics, and a section editor in the protein and proteomics section of the MDPI-Life journal.